相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Therapeutic approaches to enhance natural killer cell cytotoxicity against cancer: the force awakens
Richard W. Childs et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
Genetic manipulation of NK cells for cancer immunotherapy: techniques and clinical implications
Mattias Carlsten et al.
FRONTIERS IN IMMUNOLOGY (2015)
Design and development of therapies using chimeric antigen receptor-expressing T cells
Gianpietro Dotti et al.
IMMUNOLOGICAL REVIEWS (2014)
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
Marco L. Davila et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Mesothelin-Specific Chimeric Antigen Receptor mRNA-Engineered T Cells Induce Antitumor Activity in Solid Malignancies
Gregory L. Beatty et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Melanoma immunotherapy using mature DCs expressing the constitutive proteasome
Jens Dannull et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Bringing natural killer cells to the clinic: ex vivo manipulation
Richard W. Childs et al.
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2013)
Engineering lymph node homing of ex vivo-expanded human natural killer cells via trogocytosis of the chemokine receptor CCR7
Srinivas S. Somanchi et al.
BLOOD (2012)
A clinically adaptable method to enhance the cytotoxicity of natural killer cells against B-cell malignancies
Noriko Shimasaki et al.
CYTOTHERAPY (2012)
Expression of chimeric antigen receptors in natural killer cells with a regulatory-compliant non-viral method
L. Li et al.
CANCER GENE THERAPY (2010)
Correlation of FCGR3A and EGFR germline polymorphisms with the efficacy of cetuximab in KRAS wild-type metastatic colorectal cancer
Jan Pander et al.
EUROPEAN JOURNAL OF CANCER (2010)
Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2
Richard A. Morgan et al.
MOLECULAR THERAPY (2010)
Arrestin 3 mediates endocytosis of CCR7 following ligation of CCL19 but not CCL21
Melissa A. Byers et al.
JOURNAL OF IMMUNOLOGY (2008)
Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer
JS Miller et al.
BLOOD (2005)
Polymorphisms in FcγRIIIA (CD 16) receptor expression are associated with clinical response to rituximab in Waldenstrom's macroglobulinemia
SP Treon et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Two immunoglobulin G fragment C receptor polymorphisms independently predict response to rituximab in patients with follicular lymphoma
WK Weng et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
分享论文
